Clinical trial reportCirculation. Arrhythmia and electrophysiologyPublished
Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201)
Regional connection
Verified An author affiliation on the Europe PMC record names Lankenau Institute for Medical Research, with Main Line Health linked by the institution reference. Affiliation source
- Institutions
- Lankenau Institute for Medical Research, Main Line Health
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Circulation. Arrhythmia and electrophysiology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Atrial Fibrillation; Benzoates; Treatment Outcome; Double-Blind Method; Aged; Female; Male; Nasal Sprays; Heart rate; Atrial fibrillation; ECG
- PubMed ID
- 37950726
- PubMed Central ID
- PMC10734780
- Open access
- Yes, open
- Added to directory
- Source checked